|
Biomarkers |
Abbr. |
Specimen |
Expected values |
Expected values |
Measuring range |
Inflammation |
Procalcitonin |
PCT |
Serum/Whole Blood |
·Indicate sepsis and bacterial infection |
<0.05 ng/mL |
0.05-100 ng/mL |
Full Range C-reactive Protein |
CRP |
Plasma/Whole Blood |
·Low risk of cardiovascular disease |
hs-CRP:<1.0 mg/L |
0.5-200 mg/L |
|
C-reactive Protein/Amyloid proteinase A 2-in-1 |
CRP/SAA |
Serum/Plasma/Whole Blood |
·Low risk of cardiovascular disease |
hs-CRP:<1.0 mg/L |
CRP: 0.5-200 mg/L |
|
Immune |
Rheumatism 3-in-1 |
ASO/RF/CRP |
Serum/Plasma/Whole Blood |
·Indicators of systemic inflammation |
ASO:≦200 IU/mL |
ASO:50-500 IU/mL |
*Anti cyclic citrullinated peptide antibody |
Anti-CCP |
Serum/Plasma/Whole Blood |
·Assistant diagnostic indexe of rheumatoid arthritis |
≦25 U/mL |
25-1000 U/mL |
|
Cardiovascular |
Cardiac Troponin I |
cTnI |
Serum/Plasma/Whole Blood |
·Diagnose AMI, risk stratification and evaluate prognosis |
≦0.3 ng/mL |
0.1-50 ng/mL |
Creatine Kinase-MB |
CK-MB |
Serum/Plasma/Whole Blood |
·Negative exclusion of early AMI; Detection of recurrence and thrombolytic therapy |
≦5 ng/mL |
1-100 ng/mL |
|
Myoglobin |
MYO |
Serum/Plasma/Whole Blood |
·Early diagnosis of AMI |
≦70 ng/mL |
5-500 ng/mL |
|
Myocardial Infarction (MI) 3-in-1 |
cTnI/MYO/ |
Serum/Plasma/Whole Blood |
·Same as above 3 markers |
cTnI:≦0.3 ng/mL |
cTnI: 0.1-50 ng/mL |
|
D-Dimer(D-Dimer) |
D-Dimer |
Plasma/Whole Blood |
·Exclusion and diagnosis of venous thromboembolism |
≦0.5 mg/L |
0.1-10 mg/L |
|
N-terminal B-type natriuretic peptide |
NT-proBNP |
Serum/Plasma/Whole Blood |
·Diagnosis heart failure, risk stratification and prognostic evaluation |
≦300 pg/mL |
50-35000 pg/mL |
|
*Lipoprotein-Associated Phospholipase A2 |
Lp-PLA2 |
Serum/Plasma/Whole Blood |
·Indicating the stability of atherosclerotic plaque |
≦200ng/mL |
20-1000 ng/mL |
|
*cTnI/NT-proBNP/D-Dimer 3-in-1 |
cTnI/ |
Plasma/Whole Blood |
·Same as above 3 markers |
cTnI:≦0.3 ng/mL |
cTnI: 0.1-50 ng/mL |
|
Digestion |
*Pepsinogen I/ Pepsinogen II & 2-in-1 |
PGI/PGII |
Serum/Plasma/Whole Blood |
·Screening of high risk population of gastric cancer |
PGI<70 ng/mL |
PGI: 5-300 ng/mL |
*Gastrin 17 |
G17 |
Serum/Plasma/Whole Blood |
Reflecting both the structure and funtion of the stomach antrum. |
1-7 pmol/L |
1-50 pmol/L |
|
Anaemia |
Ferritin |
FER |
Serum/Plasma/Whole Blood |
·One of the diagnostic indexes of invisible iron deficiency anemia and liver disease |
Male(age 20-60):30-400 μg/L |
5-1000 μg/L |
Diabetes & Renal Injury |
β_2-Microglobulin |
β2-MG |
Serum/Urine |
·Sensitive indicators of crypto acute and chronic kidney diseases |
Urine:0.10-0.30mg/L |
0.1-20 mg/L |
Cystatin C |
Cys-C |
Serum |
·Detection indexes of early diabetic nephropathy and hypertensive nephropathy |
0.57-1.01 mg/L |
0.2-10 mg/L |
|
Neutrophil Gelatinase-Associated Lipocalin |
NGAL |
Urine |
·Early diagnosis of acute kidney injury (AKI) |
<131.7 ng/mL |
5-1500 ng/mL |
|
Urine Microalbumin |
mAlb |
Urine |
·Reflect the situation of early nephropathy and renal injury |
≦20 mg/L |
5-300mg/mL |
|
C-Peptide |
C-P |
Serum |
·Classification of diabetes mellitus and judgment of islet function |
1.1-4.4 ng/mL |
0.1-40 ng/mL |
|
Glycosylated Hemoglobin |
HbA1c |
Whole Blood |
·One of the indexes for diagnosis and screening of diabetes mellitus |
4.0%-6.0% |
4.0%-14% |
|
Bone Metabolism |
25-Hydroxy-Vitamin D |
25(OH)VD |
Serum/Plasma/Whole Blood |
·Diagnosis and detection of rickets (children), osteomalacia, postmenopausal osteoporosis and nephropathy |
≧30 ng/mL |
4-60 ng/mL |
Fertility |
*Total β subunit human chorionic gonadotropin |
β-HCG |
Serum/Plasma/Whole Blood |
·For the diagnosis of early pregnancy. |
<5 mIU/L |
5-30000 mIU/L |
*Progesterone |
PROG |
Serum/Plasma/Whole Blood |
·Track ovulation and placenta function |
Male: 0.14-2.06 ng/mL |
0.30-40.00 ng/mL |
|
Thyroid Hormone |
*Thyroid-stimulating hormone |
TSH |
Serum/Plasma/Whole Blood |
·Evaluation of therapeutic effect and prognosis of thyroid diseases |
0.51-6.27 mIU/L |
0.1-100 mIU/L |
*Triiodothyronine/Thyroxine & 2-in-1 |
TT3/TT4 |
Serum/Plasma/Whole Blood |
·Detection indexes of hyperthyroidism, hypothyroidism, thyroiditis and hypothalamic lesions |
TT3: 0.92-2.79 nmol/L |
TT3: 0.6-12.30 nmol/L |